Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice

The study of predictors of adverse outcomes in liver failure is driven by the rapid increase in patients with obstructive jaundice (OJ) and the lack of standardized diagnostic criteria for assessing liver functional status.Aim. To investigate the changes of liver injury biomarkers in liver failure a...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Mamoshina, M. V. Petrova, A. V. Mamoshin
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2025-04-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/2541
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410355375112192
author I. V. Mamoshina
M. V. Petrova
A. V. Mamoshin
author_facet I. V. Mamoshina
M. V. Petrova
A. V. Mamoshin
author_sort I. V. Mamoshina
collection DOAJ
description The study of predictors of adverse outcomes in liver failure is driven by the rapid increase in patients with obstructive jaundice (OJ) and the lack of standardized diagnostic criteria for assessing liver functional status.Aim. To investigate the changes of liver injury biomarkers in liver failure associated with OJ.Materials and Methods. A prospective observational cohort study was conducted on serum biomarkers of liver injury — L-FABP protein, 5'-nucleotidase, liver arginase, and hyaluronic acid — in patients with liver failure due to benign OJ. The study included 53 patients who underwent biliary decompression. Based on the course of disease, patients were divided into two groups: those with favorable outcomes (group 1, N=27) and those with unfavorable outcomes (group 2, N=26). A control group consisted of 25 healthy donors. Serum biomarker levels were assessed on admission and on days 3, 7 and 11 post-decompression. The study used enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using IBM SPSS Statistics 22, including Friedman two-way analysis, Kruskal–Wallis H test, Mann–Whitney U test, and two-sample Kolmogorov–Smirnov test, with significance set at P<0.05.Results. At hospital admission, median biomarker levels were significantly higher in both patient groups than in the comparison group. Group 1 showed a statistically significant decrease in all biomarkers during treatment (P=0.01 for L-FABP, 5'-nucleotidase, liver arginase; P=0.03 for hyaluronic acid). In group 2, only L-FABP levels decreased significantly (P=0.04). Sensitivity and specificity for predicting disease outcome were 89.2–92.3% and 88.9–96.3% for L-FABP, 53.8–69.2% and 81.5–85.2% for 5'-nucleotidase, 57.7–76.9% and 77.8–88.9% for arginase, and 38.5–46.2% and 74.1–81.5% for hyaluronic acid, respectively.Conclusion. Among the studied biomarkers, L-FABP showed the highest specificity and sensitivity values for prediction of outcome in liver failure associated with OJ, while other biomarkers demonstrated less significant results.
format Article
id doaj-art-d03f974a249a43bebcb7625447560756
institution Kabale University
issn 1813-9779
2411-7110
language English
publishDate 2025-04-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj-art-d03f974a249a43bebcb76254475607562025-08-20T03:35:08ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102025-04-01212162410.15360/1813-9779-2025-2-25411994Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive JaundiceI. V. Mamoshina0M. V. Petrova1A. V. Mamoshin2Oryol Regional Clinical HospitalFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology; Medical Institute, Patrice Lumumba Peoples Friendship University of RussiaA.V. Vishnevsky National Medical Research Center for Surgery, Ministry of Health of RussiaThe study of predictors of adverse outcomes in liver failure is driven by the rapid increase in patients with obstructive jaundice (OJ) and the lack of standardized diagnostic criteria for assessing liver functional status.Aim. To investigate the changes of liver injury biomarkers in liver failure associated with OJ.Materials and Methods. A prospective observational cohort study was conducted on serum biomarkers of liver injury — L-FABP protein, 5'-nucleotidase, liver arginase, and hyaluronic acid — in patients with liver failure due to benign OJ. The study included 53 patients who underwent biliary decompression. Based on the course of disease, patients were divided into two groups: those with favorable outcomes (group 1, N=27) and those with unfavorable outcomes (group 2, N=26). A control group consisted of 25 healthy donors. Serum biomarker levels were assessed on admission and on days 3, 7 and 11 post-decompression. The study used enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using IBM SPSS Statistics 22, including Friedman two-way analysis, Kruskal–Wallis H test, Mann–Whitney U test, and two-sample Kolmogorov–Smirnov test, with significance set at P<0.05.Results. At hospital admission, median biomarker levels were significantly higher in both patient groups than in the comparison group. Group 1 showed a statistically significant decrease in all biomarkers during treatment (P=0.01 for L-FABP, 5'-nucleotidase, liver arginase; P=0.03 for hyaluronic acid). In group 2, only L-FABP levels decreased significantly (P=0.04). Sensitivity and specificity for predicting disease outcome were 89.2–92.3% and 88.9–96.3% for L-FABP, 53.8–69.2% and 81.5–85.2% for 5'-nucleotidase, 57.7–76.9% and 77.8–88.9% for arginase, and 38.5–46.2% and 74.1–81.5% for hyaluronic acid, respectively.Conclusion. Among the studied biomarkers, L-FABP showed the highest specificity and sensitivity values for prediction of outcome in liver failure associated with OJ, while other biomarkers demonstrated less significant results.https://www.reanimatology.com/rmt/article/view/2541obstructive jaundiceliver failurebiomarkers of liver injuryl-fabp5'-nucleotidaseliver arginasehyaluronic acid
spellingShingle I. V. Mamoshina
M. V. Petrova
A. V. Mamoshin
Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice
Общая реаниматология
obstructive jaundice
liver failure
biomarkers of liver injury
l-fabp
5'-nucleotidase
liver arginase
hyaluronic acid
title Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice
title_full Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice
title_fullStr Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice
title_full_unstemmed Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice
title_short Biochemical Predictors of Clinical Outcome in Liver Failure Associated with Obstructive Jaundice
title_sort biochemical predictors of clinical outcome in liver failure associated with obstructive jaundice
topic obstructive jaundice
liver failure
biomarkers of liver injury
l-fabp
5'-nucleotidase
liver arginase
hyaluronic acid
url https://www.reanimatology.com/rmt/article/view/2541
work_keys_str_mv AT ivmamoshina biochemicalpredictorsofclinicaloutcomeinliverfailureassociatedwithobstructivejaundice
AT mvpetrova biochemicalpredictorsofclinicaloutcomeinliverfailureassociatedwithobstructivejaundice
AT avmamoshin biochemicalpredictorsofclinicaloutcomeinliverfailureassociatedwithobstructivejaundice